News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,300 Results
Type
Article (44275)
Company Profile (311)
Press Release (706695)
Multimedia
Podcasts (128)
Webinars (22)
Section
Business (211177)
Career Advice (2116)
Deals (36815)
Drug Delivery (142)
Drug Development (83566)
Employer Resources (176)
FDA (16926)
Job Trends (15539)
News (357825)
Policy (34151)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2641)
Accelerated approval (47)
Adcomms (28)
Allergies (177)
Alliances (51589)
ALS (215)
Alzheimer's disease (1824)
Antibody-drug conjugate (ADC) (462)
Approvals (17312)
Artificial intelligence (695)
Autoimmune disease (298)
Automation (57)
Bankruptcy (373)
Best Places to Work (11768)
BIOSECURE Act (21)
Biosimilars (229)
Biotechnology (184)
Bladder cancer (196)
Brain cancer (76)
Breast cancer (763)
Cancer (5918)
Cardiovascular disease (487)
Career advice (1802)
Career pathing (43)
CAR-T (336)
CDC (59)
Celiac Disease (3)
Cell therapy (916)
Cervical cancer (47)
Clinical research (72469)
Collaboration (2127)
Company closure (5)
Compensation (1413)
Complete response letters (88)
COVID-19 (2817)
CRISPR (114)
C-suite (1168)
Cystic fibrosis (157)
Data (7985)
Decentralized trials (3)
Denatured (38)
Depression (166)
Dermatology (87)
Diabetes (594)
Diagnostics (7024)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (332)
Drug pricing (220)
Drug shortages (34)
Duchenne muscular dystrophy (287)
Earnings (93865)
Editorial (69)
Employer branding (21)
Employer resources (155)
Events (122538)
Executive appointments (1113)
FDA (20710)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1750)
Gene editing (241)
Generative AI (59)
Gene therapy (746)
GLP-1 (1106)
Government (4876)
Grass and pollen (7)
Guidances (409)
Healthcare (19193)
HIV (79)
Huntington's disease (57)
IgA nephropathy (99)
Immunology and inflammation (303)
Immuno-oncology (95)
Indications (195)
Infectious disease (3157)
Inflammatory bowel disease (224)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (296)
Interviews (330)
IPO (16946)
IRA (57)
Job creations (4074)
Job search strategy (1500)
JPM (65)
Kidney cancer (19)
Labor market (101)
Layoffs (592)
Leadership (41)
Legal (8427)
Liver cancer (101)
Longevity (33)
Lung cancer (774)
Lymphoma (432)
Machine learning (62)
Management (60)
Manufacturing (1084)
MASH (196)
Medical device (14025)
Medtech (14150)
Mergers & acquisitions (21122)
Metabolic disorders (1545)
mRNA (218)
Multiple sclerosis (188)
NASH (18)
Neurodegenerative disease (424)
Neuropsychiatric disorders (109)
Neuroscience (3366)
Neurotech (1)
NextGen: Class of 2026 (6646)
Non-profit (4578)
Now hiring (78)
Obesity (727)
Opinion (314)
Ovarian cancer (223)
Pain (274)
Pancreatic cancer (306)
Parkinson's disease (364)
Partnered (34)
Patents (606)
Patient recruitment (679)
Peanut (65)
People (61658)
Pharmaceutical (84)
Pharmacy benefit managers (34)
Phase 1 (22488)
Phase 2 (31897)
Phase 3 (23864)
Pipeline (8900)
Policy (336)
Postmarket research (2660)
Preclinical (9606)
Press Release (68)
Prostate cancer (306)
Psychedelics (57)
Radiopharmaceuticals (332)
Rare diseases (1117)
Real estate (6323)
Recruiting (72)
Regulatory (26332)
Reports (57)
Research institute (2463)
Resumes & cover letters (362)
Rett syndrome (39)
RNA editing (24)
RSV (88)
Schizophrenia (185)
Series A (295)
Series B (216)
Service/supplier (11)
Sickle cell disease (115)
Special edition (27)
Spinal muscular atrophy (169)
Sponsored (49)
Startups (3792)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (99)
The Weekly (88)
Vaccines (1124)
Venture capital (110)
Weight loss (477)
Women's health (129)
Worklife (20)
Date
Today (163)
Last 7 days (803)
Last 30 days (3635)
Last 365 days (30661)
2026 (12990)
2025 (30677)
2024 (35758)
2023 (40626)
2022 (51797)
2021 (56326)
2020 (54789)
2019 (47396)
2018 (35767)
2017 (33135)
2016 (32661)
2015 (38614)
2014 (32517)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (806)
Alabama (93)
Alaska (7)
Arizona (356)
Arkansas (16)
Asia (42626)
Australia (6848)
California (13400)
Canada (3804)
China (1387)
Colorado (570)
Connecticut (582)
Delaware (414)
Europe (91795)
Florida (2005)
Georgia (427)
Hawaii (3)
Idaho (62)
Illinois (1074)
India (93)
Indiana (611)
Iowa (23)
Japan (554)
Kansas (133)
Kentucky (50)
Louisiana (43)
Maine (76)
Maryland (1605)
Massachusetts (9600)
Michigan (367)
Minnesota (726)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (144)
New Hampshire (84)
New Jersey (3518)
New Mexico (30)
New York (3513)
North Carolina (1719)
North Dakota (9)
Northern California (6706)
Ohio (401)
Oklahoma (24)
Oregon (46)
Pennsylvania (2700)
Puerto Rico (29)
Rhode Island (50)
South America (1179)
South Carolina (87)
South Dakota (2)
Southern California (5295)
Tennessee (213)
Texas (2139)
United States (47383)
Utah (401)
Vermont (1)
Virginia (338)
Washington D.C. (80)
Washington State (1072)
West Virginia (4)
Wisconsin (134)
Wyoming (2)
751,300 Results for "enanta pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026
May 12, 2026
·
14 min read
Press Releases
Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference
March 3, 2026
·
1 min read
Press Releases
Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus and STAT6 Inhibitor Programs at the American Thoracic Society International Conference 2026
May 4, 2026
·
2 min read
Press Releases
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria
April 13, 2026
·
5 min read
Press Releases
Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026
April 7, 2026
·
2 min read
Press Releases
Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)
March 30, 2026
·
2 min read
Press Releases
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
February 10, 2026
·
13 min read
Press Releases
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
January 8, 2026
·
11 min read
Press Releases
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
1 min read
Press Releases
Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting
February 10, 2026
·
2 min read
1 of 75,130
Next
